Ado-trastuzumab emtansine Intravenous and Indium DTPA
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Indium DTPA and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: indium pentetate in-111
Brand name:
Synonyms: Pentetate Indium Disodium In 111, In-111 DTPA
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Indium In-111 Pentetreotide
- Ado-trastuzumab emtansine Intravenous-Indium Oxyquinoline
- Ado-trastuzumab emtansine Intravenous-Indocid
- Ado-trastuzumab emtansine Intravenous-Indocin
- Ado-trastuzumab emtansine Intravenous-Indocin (Indomethacin Suppositories)
- Ado-trastuzumab emtansine Intravenous-Indocin (Indomethacin Suspension)
- Indium DTPA-Adox Pak 2/100
- Indium DTPA-Adoxa
- Indium DTPA-Adoxa CK
- Indium DTPA-Adoxa Pak
- Indium DTPA-Adoxa Pak 1/100
- Indium DTPA-Adoxa Pak 1/150